|
|
|
|
|
|
by throwup238
626 days ago
|
|
|
Only for orphan and ultra orphan diseases where there are so few patients that it’s not economically viable to do full clinical trials. There is also a breakthrough therapy designation where the clinical evidence is solid enough to release the drug while they finish full trials but that’s only in exceptional cases. |
|
|